Most Read Articles
5 days ago
Living a sedentary lifestyle may increase the risk of cardiovascular diseases (CVD) even in people with healthy body mass index (BMI), reports a new study.
04 Feb 2019
The carbon-chain length of saturated fatty acids appears to be an important factor in determining its role in cardiovascular health, a recent study has found.
3 days ago
Olanzapine confers a modest therapeutic effect on weight compared with placebo in adult outpatients with anorexia nervosa, a study has shown. However, it does not appear to offer significant benefit for psychological symptoms.
Jairia Dela Cruz, 04 Feb 2019
Treatment with secukinumab results in a higher rate of remission or low-disease activity at week 16 in patients with psoriatic arthritis as compared with placebo, according to a posthoc analysis of the FUTURE 2 study. This effect is sustained at 2 years and is evident in both tumour necrosis factor inhibitor-experienced and -naïve patients.

6-minute walk test reproducible, useful in systemic sclerosis

07 Oct 2018

A recent study has demonstrated the robust reproducibility for the 6-minute walk distance (6MWD) and established the utility of the 6-minute walk test (6MWT) in examining the overall prognosis of patients with systemic sclerosis (SSc).

In total, 56 patients (aged 46±12.7 years; 38 female), with 17±10 modified Rodnan skin score (mRSS) and 1±0.8 Scleroderma Health Assessment Questionnaire (SHAQ) at first referral, were included. Overall, 277 6MWT assessments (5±3.9 6MWT per patient) were conducted over 23±22.5 months of follow-up. There were eight deaths (87.5 percent SSc-related) reported.

The 6MWD absolute value had a mean of 457±117 m, with a mean Borg dyspnoea score of 4±2.2. The 6MWD intraclass correlation coefficient was 0.996 (95 percent CI, 0.995–0.999; p<0.0001).

Multivariate linear regression analysis showed the following factors to be independently associated with a lower 6MWD: sex (R2, 0.47; p<0.0001), mRSS (R2, 0.47; p=0.008), tendon friction rub (R2, 0.47; p=0.003), SHAQ (R2, 0.47; p=0.02), muscle disability score (R2, 0.47; p=0.03), DLCO% (R2, 0.47; p=0.0008), and left ventricular ejection fraction (R2, 0.47; p=0.006).

The 6MWD at first referral independently predicted overall mortality (hazard ratio [HR], 0.99; 0.988–0.999) and SSc-related mortality (HR, 0.99; 0.988–0.999).

This observational study consecutively enrolled all patients with SSc who underwent at least two 6MWT within a minimum 3-month interval plus simultaneous routine clinical, biological and functional evaluations over 6 years. In compliance with the American Thoracic Society guidelines, each 6MWT was repeated twice to assess the reproducibility of the 6MWD, with the highest value being reported for subsequent analysis.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
Living a sedentary lifestyle may increase the risk of cardiovascular diseases (CVD) even in people with healthy body mass index (BMI), reports a new study.
04 Feb 2019
The carbon-chain length of saturated fatty acids appears to be an important factor in determining its role in cardiovascular health, a recent study has found.
3 days ago
Olanzapine confers a modest therapeutic effect on weight compared with placebo in adult outpatients with anorexia nervosa, a study has shown. However, it does not appear to offer significant benefit for psychological symptoms.
Jairia Dela Cruz, 04 Feb 2019
Treatment with secukinumab results in a higher rate of remission or low-disease activity at week 16 in patients with psoriatic arthritis as compared with placebo, according to a posthoc analysis of the FUTURE 2 study. This effect is sustained at 2 years and is evident in both tumour necrosis factor inhibitor-experienced and -naïve patients.